Search results
Michael Andrew Fox OC (born June 9, 1961), known professionally as Michael J. Fox, is a Canadian and American activist and retired actor. Beginning his career as a child actor in the 1970s, he rose to prominence portraying Alex P. Keaton on the NBC sitcom Family Ties (1982–1989) and Marty McFly in the Back to the Future film trilogy (1985 ...
Apr 3, 2024 · Michael J. Fox and wife Tracy Pollan at the A Country Thing Happened On The Way To Cure Parkinson's at The Fisher Center for the Performing Arts on April 02, 2024 in Nashville, Tennessee.
IMDb provides an extensive overview of Michael J. Fox's life and career, from his birth in Canada to his roles in Back to the Future, Family Ties, Spin City and more. You can also find his contact info, photos, videos, trivia, FAQ and IMDbPro data.
- January 1, 1
- 1.63 m
- Edmonton, Alberta, Canada
Apr 5, 2024 · Michael J. Fox, Canadian American actor and activist who rose to fame in the 1980s for his comedic roles and who later became involved in Parkinson disease research after being diagnosed with the disorder. His notable credits included the TV show Family Ties and the Back to the Future movie series.
- The Editors of Encyclopaedia Britannica
People also ask
Did Michael J Fox really pass away?
How many children does Michael J Fox have?
Does Michael J. Fox have a disability?
What health issues does Michael J . Fox have?
Michael J. Fox, iconic actor, author and advocate whose Hollywood career has been marked by worldwide acclaim, honor and awards, launched the Foundation in 2000 after publicly disclosing his 1991 diagnosis, at age 29, with Parkinson’s disease. Michael Andrew Fox was born in 1961 in Alberta, Canada. A self-described "army brat," Fox moved many ...
1 day ago · I know Michael J. Fox. Like, I know him pretty damn well. He’s funny. He’s warm. He’s handsome and intensely smart. He also falls a lot. Not just because he has Parkinson’s. He falls a lot ...
The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.